Company Filing History:
Years Active: 1998-2002
Title: The Innovations of Molly McClarrinon
Introduction
Molly McClarrinon is an accomplished inventor based in San Francisco, CA. She has made significant contributions to the field of gene targeting through her innovative inventions. With a total of 2 patents, her work focuses on pharmaceutical compositions and methods for the targeted delivery of functional genes into cells and tissues.
Latest Patents
Molly's latest patents include groundbreaking inventions related to cationic lipid:DNA complexes for gene targeting. These inventions describe pharmaceutical compositions and methods for the targeted delivery of functional genes into cells and tissues in vivo. The patents disclose DNA:lipid complexes, methods of making such complexes, and methods of using these complexes to facilitate the targeted delivery and entry of recombinant expression constructs into cells and tissues. This targeted delivery can be achieved through various methods, including intravenous, intraperitoneal, or direct injection.
Career Highlights
Throughout her career, Molly has worked with notable companies such as Megabios Corporation and Valentis, Inc. Her experience in these organizations has allowed her to develop her expertise in gene therapy and related technologies.
Collaborations
Molly has collaborated with various professionals in her field, including her coworker Cori M Gorman. Their partnership has contributed to the advancement of innovative solutions in gene targeting.
Conclusion
Molly McClarrinon is a pioneering inventor whose work in gene targeting has the potential to revolutionize the field of gene therapy. Her contributions through her patents and collaborations highlight her commitment to advancing medical science.